RPS15 and esophageal squamous cell carcinoma: Meanwhile, RPS15 inhibition with folic acid, IGF2BP1 knockout, or treatment with SB203580 will suppress ESCC metastasis and proliferation via the p38 MAPK signaling pathway (Fig. 8).